Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-03-07

Clinical Trial Update: The Role of Sugammadex in Posotoperative Urinary Retention in Patients Undergoing Pelvic Floor Reconstructive Procedures [Phase 1, Phase 2]

View source ↗

Summary

A phase 1/2 clinical trial evaluating sugammadex for postoperative urinary retention in patients undergoing pelvic floor reconstructive procedures has been with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sugammadex (sugammadex)

Snippet

Sponsor: West Virginia University | Conditions: Postoperative Urinary Retention | Phase 1, Phase 2 | Status: WITHDRAWN